$NHI

BMO reiterates Outperform on National Health Investors stock

BMO Capital reiterated an Outperform rating and $80.00 price target on National Health Investors (NHI). The company, trading near its 52-week low, focuses on growth through acquisitions and its SHOP portfolio. NHI reported Q2 2026 earnings beating profit expectations but missing revenue forecasts, with a dividend increase and asset sale gains. Truist Securities lowered its price target to $80, maintaining a Buy rating.

Original reporting
Published Sep 23, 2026, 2:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 3:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NHI
Bullish
medium confidence
Mentioned
$NHI
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NHIBullishMed
01

Why it matters

Analyst upgrades and dividend increase reinforce a bullish short-term outlook.

02

Market read

Earnings beat and dividend hike provide actionable insight for traders in the REIT space.

03

What to watch

Potential headwinds from CFO transition and deferred tax expenses could affect future performance.

Relevance 6/10Novelty 7/10Timing: after-hours release

Background

BMO Capital reiterates Outperform on NHI with $80 price target; Truist lowers target to $80.

Company-level read

Ticker impact

$NHIBullishMedium confidence
Context

Q2 2026 earnings beat EPS estimate and dividend increase; sale of NHC portfolio for $560M disclosed.

Expected impact

Potential modest price rise ahead of next trading session.

Evidence & confidence

Earnings beat, dividend raise, and large portfolio sale provide fresh, material information for investors.

Market effects

May boost sentiment in REIT and senior housing sectors.

Limited to U.S. REIT market.

Low

Counterpoint

The earnings beat may be offset by lower-than-expected revenue and compressing acquisition yields.

Key entities

  • National Health Investors

    REIT focused on senior housing and health care properties.

  • BMO Capital

    Maintains Outperform rating and $80 price target.

Related articles

$NHIMed

Senior Housing Deal Could Be A Game Changer For National Health Investors Stock

National Health Investors (NYSE:NHI) invested $107.7M to acquire six senior housing properties, expanding its SHOP segment. The deal increases its partnership with Allegro Living Management and adds 443 units across three states. Analysts project revenues of $516.5M and earnings of $154.7M by 2029, with a potential 25% upside. However, risks include occupancy softness, labor strain, and integration challenges.

$LTCHighAI 8/10

Senior Living Dealbook: LTC Completes $160M Acquisition; NHI Invests $107.7M in SHOP Expansion

LTC Properties (LTC) acquired three senior housing communities for $160M, adding 270 units. National Health Investors (NHI) invested $107.7M in six communities, adding 443 units. Both companies are expanding their senior housing portfolios. Cardinal Senior Living acquired three Ohio communities. Other transactions include sales in Michigan, New York, New Mexico, and South Carolina. JLL arranged $276M in refinancing for a California senior housing portfolio.

$NHIMed

NHI Announces $107.7 Million SHOP Investment

National Health Investors (NHI) announced a $107.7M investment in six properties with 443 units in Kentucky, Michigan, and Tennessee. The properties will be part of NHI's Senior Housing Operating Portfolio (SHOP) segment and managed by Allegro Living Management. NHI expects an initial NOI yield of 7.0% and 6.6% after capital expenditures. The company also has $164.3M in investment opportunities under signed LOIs and $51.7M in real estate purchase options.

$NHIHighAI 8/10

NHI (NHI) Q2 2026 Earnings Call Transcript

NHI reported Q2 2026 earnings with net income per share up 45.6% to $1.15, driven by real estate sales. NAREIT FFO per share remained flat at $1.19, while normalized FFO per share decreased 2.5% due to transition costs. The company completed a $560M portfolio sale, increasing liquidity and reducing leverage. NHI plans to expand its senior housing operating portfolio (SHOP) to 40-50% of its total portfolio within three years, with $127.3M in new investments under signed letters of intent. The qua

$NHIMed

National Health Investors, Inc. Q2 2026 Earnings Call Summary

National Health Investors (NHI) reported Q2 2026 updates, including completion of the NHC portfolio sale on July 1 and plans to redeploy $334 million via Section 1031 exchanges. It said SHOP investment rose 137% to about $850 million and targets 40% to 50% of total NOI over three years. Management guided for 8% to 9% same-store SHOP NOI growth in 2H.